ABOUT LUMAKRAS™ (SOTORASIB)

HOW LUMAKRAS™ WORKS

Lumakras icon
  • LUMAKRAS™ is specifically designed for tumors with the KRAS G12C mutation1
  • In tumors with this KRAS mutation, the protein remains mostly in an “on” position, and cells are continuously forced to grow2
  • LUMAKRAS™ targets the mutated KRAS protein and locks it in the “off” position. This may prevent tumor cell growth3
green-round-icon

If your cancer is KRAS G12C positive and has been treated with a prior therapy, such as chemotherapy or immunotherapy, ask your doctor if LUMAKRAS™ may be able to help.1

NEXT: CLINICAL TRIAL RESULTS